Sort
50,496 grants matching “lung cancer”
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
$539,540Keith D Robertson · Mayo Clinic Rochester · R01 · FY2025 · CA
Alpha Emitter Labeled Anti-T Cell Antibody: Targeting Latent HIV Infected Cells
$539,534Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · R33 · FY2016 · AI
CAREER: Predictive Multiscale Modeling of Cell Migration through Pores between Endothelial Cells
$539,532Zhangli Peng · University Of Illinois At Chicago · · FY2024 · ENG
Culturally and Linguistically Adapted Physical Activity Intervention for Latinas
$539,523Bess Hya Marcus · University Of California, San Diego · R01 · FY2012 · NR
UNBIASED MICROFLUIDICS-BASED ISOLATION OF ANTIGEN-SPECIFIC T CELLS IN NON- SMALL CELL LUNG CANCER
$539,453The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency
Analysis of Tumor Dynamics in Progression and Metastasis
$539,304University Of Pennsylvania · U01 · FY2004 · CA
Preclinical Electron Paramagnetic Resonance Tumor Imager
$539,291Gareth R Eaton · University Of Denver (Colorado Seminary) · R01 · FY2021 · CA
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
$539,269Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Oral microbiome in esophageal adenocarcinoma
$539,256Zhiheng Pei · New York University School Of Medicine · U01 · FY2017 · CA
Oral microbiome in esophageal adenocarcinoma
$539,256Zhiheng Pei · New York University School Of Medicine · U01 · FY2015 · CA
Oral microbiome in esophageal adenocarcinoma
$539,256Zhiheng Pei · New York University School Of Medicine · U01 · FY2016 · CA
Oral microbiome in esophageal adenocarcinoma
$539,256Zhiheng Pei · New York University School Of Medicine · U01 · FY2014 · CA
Radon on the RADAR
$539,177Ellen J Hahn · University Of Kentucky · R01 · FY2021 · ES
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$539,112Brian E Henderson · University Of Southern California · U01 · FY2010 · CA
Characterization and modeling of m6A RNA methylation in cancer
$539,031Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Characterization and modeling of m6A RNA methylation in cancer
$539,031Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
The effect of oxygen gradients on sarcoma invasiveness through dynamic collagen modulation
$539,020Sharon Gerecht · Johns Hopkins University · U54 · FY2017 · CA
OVERCOMING ANTI-PD-1 RESISTANCE IN LUNG CANCER
$539,000University Of Louisville · · FY2019 · Department of the Army
NONCANONICAL ROLE FOR PHOSPHOSERINE AMINOTRANSFERASE 1 (PSAT1) IN PROMOTING EGFR-MUTANT LUNG CANCER METASTASIS
$538,990University Of Louisville · · FY2019 · Defense Health Agency
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
$538,965Peter Kent Jackson · Stanford University · U01 · FY2019 · CA
Immune modulation of radiation therapy with Flt3 ligand
$538,873Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2016 · CA
GENETIC AND EPIGENETIC DETERMINANTS OF LUNG CANCER SUBTYPE: ADENOCARCINOMA TO SMALL CELL CONVERSION
$538,867Sloan-Kettering Institute For Cancer Research · · FY2014 · Department of the Army
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
$538,612Georgeta-Elisabeta Marai · University Of Illinois At Chicago · R01 · FY2022 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$538,522William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
$538,509Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA